[1]
|
马丽媛, 王增武, 樊静, 胡盛寿. 《中国心血管健康与疾病报告2021》关于中国高血压流行和防治现状[J]. 中国全科医学, 2022, 25(30): 3715-3720. https://doi.org/10.12114/j.issn.1007-9572.2022.0502
|
[2]
|
中国老年医学学会高血压分会, 国家老年疾病临床医学研究中心中国老年心血管病防治联盟. 中国老年高血压管理指南2019[J]. 中国心血管杂志, 2019, 24(1): 1-23. https://doi.org/10.3969/j.issn.1007-5410.2019.01.001
|
[3]
|
邹文淑, 王剑峰, 周莉华, 陈霞, 卿秀, 周从良. 老年单纯收缩期高血压的诊治进展[J]. 中华老年心脑血管病杂志, 2014, 16(12): 1343-1344. https://doi.org/10.3969/j.issn.1009-0126.2014.12.034
|
[4]
|
中华医学会老年医学分会, 中国医师协会高血压专业委员会. 老年人高血压特点与临床诊治流程专家建议[J]. 中华老年医学杂志, 2014, 33(7): 689-701. https://doi.org/10.3760/cma.j.issn.0254-9026.2014.07.001
|
[5]
|
袁艳敏, 郭艺芳. 人体血压昼夜节律特征及其调节机制[J]. 中华高血压杂志, 2008, 16(6): 483-485.
https://doi.org/10.3969/j.issn.1673-7245.2008.06.002
|
[6]
|
胡亦新, 范利. 老年高血压合并衰弱的临床研究和管理进展——《中国老年高血压管理指南2019》解读[J]. 中华高血压杂志, 2019, 27(10): 910-913.
|
[7]
|
Dent, E., Martin, F.C., Bergman, H., et al. (2019) Management of Frailty: Opportunities, Challenges, and Future Directions. The Lancet, 394, 1376-1386. https://doi.org/10.1016/S0140-6736(19)31785-4
|
[8]
|
付梦雪, 张先庚. 老年人衰弱综合征的研究进展[J]. 护理研究, 2019, 33(17): 2973-2976.
https://doi.org/10.12102/j.issn.1009-6493.2019.17.012
|
[9]
|
马丽娜. 老年衰弱综合征的发病机制[J]. 中华老年医学杂志, 2021, 40(3): 379-382.
https://doi.org/10.3760/cma.j.issn.0254-9026.2021.03.023
|
[10]
|
宁晓暄, 欧阳敏, Leng Sean X. 老年人衰弱综合征的发病机制和评估及管理[J]. 中华老年医学杂志, 2015, 34(12): 1282-1285. https://doi.org/10.3760/cma.j.issn.0254-9026.2015.12.002
|
[11]
|
Leng, S.X., Cappola, A.R., Andersen, R.E., et al. (2004) Serum Levels of Insulin-Like Growth Factor-I (IGF-I) and Dehydroepiandrosterone Sulfate (DHEA-S), and Their Relationships with Serum Interleukin-6, in the Geriatric Syndrome of Frailty. Aging Clinical and Experimental Re-search, 16, 153-157. https://doi.org/10.1007/BF03324545
|
[12]
|
Pansarasa, O., Pistono, C., Davin, A., et al. (2019) Altered Immune System in Frailty: Genetics and Diet May Influence Inflammation. Ageing Research Reviews, 54, Article ID: 100935. https://doi.org/10.1016/j.arr.2019.100935
|
[13]
|
Clegg, A., Young, J., Iliffe, S., et al. (2013) Frailty in Elderly People. The Lancet, 381, 752-762.
https://doi.org/10.1016/S0140-6736(12)62167-9
|
[14]
|
Marcos-Pérez, D., Sánchez-Flores, M., Maseda, A., et al. (2019) Serum Cortisol but Not Oxidative Stress Biomarkers Are Related to Frailty: Results of a Cross-Sectional Study in Spanish Older Adults. Journal of Toxicology and Environmental Health, Part A, 82, 815-825. https://doi.org/10.1080/15287394.2019.1654639
|
[15]
|
尹佳慧, 曾雁冰, 周鼒, 方亚. 中国老年人衰弱状况及其影响因素分析[J]. 中华流病学杂志, 2018, 39(9): 1244- 1248. https://doi.org/10.3760/cma.j.issn.0254-6450.2018.09.019
|
[16]
|
Fried, L.P., Tangen, C.M., Walston, J., et al. (2001) Frailty in Older Adults: Evidence for a Phenotype. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 56, M146-M156.
https://doi.org/10.1093/gerona/56.3.M146
|
[17]
|
韩君, 王君俏, 谢博钦, 王悦. Fried衰弱表型和FRAIL量表及埃德蒙顿衰弱评估量表在社区高龄老年人衰弱筛查中一致性和适用性的比较研究[J]. 中国全科医学, 2021, 24(21): 2669-2675.
https://doi.org/10.12114/j.issn.1007-9572.2021.00.451
|
[18]
|
Mitnitski, A.B., Mogilner, A.J., Rockwood, K. (2001) Accumulation of Deficits as a Proxy Measure of Aging. Scientific World Journal, 1, 323-336. https://doi.org/10.1100/tsw.2001.58
|
[19]
|
Fan, J., Yu, C., Guo, Y., et al. (2020) Frailty Index and All-Cause and Cause-Specific Mortality in Chinese Adults: A Prospective Cohort Study. The Lancet Public Health, 5, e650-e660. https://doi.org/10.1016/S2468-2667(20)30113-4
|
[20]
|
董冰茹, 顾杰. 社区老年人衰弱评估方法的研究进展[J]. 中国全科医学, 2021, 24(10): 1302-1308.
https://doi.org/10.12114/j.issn.1007-9572.2021.00.012
|
[21]
|
Carmo Correia de Lima, M., Loffredo Bilton, T., Jef-ferson de Sousa Soares, W., et al. (2019) Maximum Walking Speed Can Improve the Diagnostic Value of Frailty among Community-Dwelling Older Adults: A Cross-Sectional Study. The Journal of Frailty & Aging, 8, 39-41. https://doi.org/10.14283/jfa.2018.44
|
[22]
|
Rolfson, D.B., Majumdar, S.R., Tsuyuki, R.T., et al. (2006) Validity and Reliability of the Edmonton Frail Scale. Age Ageing, 35, 526-529. https://doi.org/10.1093/ageing/afl041
|
[23]
|
中华医学会老年医学分会, 《中华老年医学杂志》编辑委员会. 老年人衰弱预防中国专家共识(2022) [J]. 中华老年医学杂志, 2022, 41(5): 503-511. https://doi.org/10.3760/cma.j.issn.0254-9026.2022.05.001
|
[24]
|
Yao, S., Zheng, P., Ji, L., et al. (2020) The Effect of Comprehensive Assessment and Multi-Disciplinary Management for the Geriatric and Frail Patient: A Multi-Center, Randomized, Parallel Controlled Trial. Medicine (Baltimore), 99, e22873. https://doi.org/10.1097/MD.0000000000022873
|
[25]
|
Ruiz, J.G., Dent, E., Morley, J.E., et al. (2020) Screening for and Managing the Person with Frailty in Primary Care: ICFSR Consensus Guidelines. Journal of Nutrition, Health and Aging, 24, 920-927.
https://doi.org/10.1007/s12603-020-1498-x
|
[26]
|
Zhang, Y., Zhang, Y., Li, Y., et al. (2020) Reliability and Validity of the Self-Reported Frailty Screening Questionnaire in Older Adults. Therapeutic Advances in Chronic Disease, 11. https://doi.org/10.1177/2040622320904278
|
[27]
|
Shang, N., Liu, H., Wang, N., et al. (2022) Comparison of Three Frailty Screening Instruments for Prediction of Adverse Outcomes among Older Adults in the Emergency Department. Geriatrics & Gerontology International, 22, 851-856.
https://doi.org/10.1111/ggi.14469
|
[28]
|
Ma, L., Tang, Z., Chan, P. and Walston, J.D. (2019) Novel Frailty Screen-ing Questionnaire (FSQ) Predicts 8-Year Mortality in Older Adults in China. The Journal of Frailty & Aging, 8, 33-38. https://doi.org/10.14283/jfa.2018.38
|
[29]
|
Kang, M.G., Kim, S.W., Yoon, S.J., et al. (2017) Association between Frailty and Hypertension Prevalence, Treatment, and Control in the Elderly Korean Population. Scientific Reports, 7, Arti-cle No. 7542.
https://doi.org/10.1038/s41598-017-07449-5
|
[30]
|
范利, 李建华, 胡亦新, 王蓉, 赵婷, 库洪安, 杨雪, 李银艺, 张曼秀. 合并不同并发症的老年高血压患者的衰弱检出率[J]. 中华高血压杂志, 2015, 23(12): 1151-1155.
|
[31]
|
谭修竹, 冯静, 王志敏, 骆沁, 唐玺, 姚可茹, 尹心红. 社区高血压患者衰弱现状及其影响因素[J]. 医学信息, 2022, 35(3): 139-142. https://doi.org/10.3969/j.issn.1006-1959.2022.03.036
|
[32]
|
Warwick, J., Falaschetti, E., Rockwood, K., et al. (2015) No Evidence That Frailty Modifies the Positive Impact of Antihypertensive Treatment in Very Elderly People: An Investigation of the Impact of Frailty upon Treatment Effect in the Hypertension in the Very El-derly Trial (HYVET) Study, a Double-Blind, Placebo-Controlled Study of Antihypertensives in People with Hyperten-sion Aged 80 and over. BMC Medicine, 13, 78.
https://doi.org/10.1186/s12916-015-0328-1
|
[33]
|
SPRINT Research Group, Wright, J.T., Williamson, J.D., et al. (2015) A Randomized Trial of Intensive versus Standard Blood-Pressure Control. The New England Journal of Medicine, 373, 2103-2116.
https://doi.org/10.1056/NEJMoa1511939
|
[34]
|
Whelton, P.K., Carey, R.M., Aronow, W.S., et al. (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiolo-gy/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71, e13-e115. https://doi.org/10.1161/HYP.0000000000000076
|
[35]
|
Williams, B., Mancia, G., Spiering, W., et al. (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. European Heart Journal, 39, 3021-3104. https://doi.org/10.1093/eurheartj/ehy339
|
[36]
|
Unger, T., Borghi, C., Charchar, F., et al. (2020) 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 75, 1334-1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
|